Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.
Tian-Cheng WangTian-Zhi AnJun-Xiang LiPeng-Fei PangPublished in: Risk management and healthcare policy (2021)
Pretreatment peripheral blood SIRI was found to be an independent predictor of tumor response and clinical outcomes in patients with HCC undergoing TACE. Patients with high SIRI may have a poor prognosis.